On this page
Zinbryta
daclizumab
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Zinbryta
Proper name
daclizumab
Licence type
351(a)
BLA number
761029
Applicant
Biogen Inc.
Center
CDER
Presentations
2
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 150MG/ML | Injection | Subcutaneous | Pre-Filled Syringe | Disc | May 27, 2016 |
| 150MG/ML | Injection | Subcutaneous | Autoinjector | Disc | May 26, 2017 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |